搜尋結果
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
The Wall Street Journal· 3 日前Amgen’s progress on its experimental weight-loss drug offered investors a ...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 7 日前A federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers ... ...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 7 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Reuters· 4 日前U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued ... ...
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
CNBC· 21 小時前This dilemma comes up quite a bit these days when Director of Portfolio Analysis Jeff Marks and ...
Pot Stocks Surge on Report DEA Set to Reclassify Marijuana
Bloomberg· 6 日前Have a confidential tip for our reporters? Shares of cannabis-related companies jumped Tuesday ...
Five Low-Debt Stocks For The “Higher For Longer” Era
Forbes· 11 小時前Jerome Powell, head of the Federal Reserve, made it official a few days ago. “Higher ... ...
Your Psychedelic Gummy Is Here. (Have A Nice Trip.)
Forbes· 1 日前There are two reasons the Wickramarachchis chose Amanita muscaria: First, it is psychoactive, ...
European Stocks Slip Amid Earnings Flood, Fed Rate Signals
Bloomberg· 4 日前European stocks posted modest losses on Thursday, pressured by drops across retail and technology and ...
At European Conference, Experts Explore What’s Next For Psychedelic Medicine
Forbes· 6 日前Prior to being approved by the U.S. Food and Drug Administration (FDA), each of those ... ...